DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Vestbo J, Anderson JA, Brook RD. et al.
Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial.
Lancet 2016;
387: 1817-1826
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.